| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | VEGI/TL1 human recombinant |
|---|
| Description | VEGI (Vascular Endothelial Growth Inhibitor) is a member of the tumor necrosis factor family. VEGI is predominantly an endothelial cell-specific gene, and recombinant VEGI is a potent inhibitor of endothelial cell proliferation, angiogenesis and tumor growth. VEGI exerts two activities of endothelial cells: early Gl arrest of G0/G1-cells responding to growth stimuli, and programmed cell death. VEGI is also able to regulate the expression of several important genes involved in angiogenesis. Human VEGF is a 21.8 kDa homodimeric protein consisting of 192 amino acid polypeptide chains. MW: 21.8 kDa. Purity ≥95% |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | Tumor necrosis factor ligand superfamily member 15, TNFSF-15, TNFSF15, TNF ligand-related molecule 1, VEGI, TL-1, TL1, TL1A, VEGI192A, VEGI-192, MGC129934, MGC129935, Vascular endothelial cell growth inhibitor. |
|---|
| Gene, Accession, CAS # | TNFSF15, Gene ID: 41019336, Accession: AAR98573 |
|---|
| Catalog # | 4966-1000 |
|---|
| Price | |
|---|
| Order / More Info | VEGI/TL1 human recombinant from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|